{"id":"NCT03389555","sponsor":"Beth Israel Deaconess Medical Center","briefTitle":"Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial","officialTitle":"Ascorbic Ccid, Hydrocortisone, and Thiamine in Sepsis and Septic Shock - A Randomized, Double-Blind, Placebo-Controlled Trial","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2018-02-09","primaryCompletion":"2019-11-26","completion":"2020-02-28","firstPosted":"2018-01-03","resultsPosted":"2021-01-29","lastUpdate":"2021-02-16"},"enrollment":205,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Sepsis","Septic Shock","Metabolic Disturbance"],"interventions":[{"type":"DRUG","name":"vitamin C, vitamin B1, hydrocortisone","otherNames":["Ascorbic Acid","Thiamine"]},{"type":"DRUG","name":"Normal saline","otherNames":[]}],"arms":[{"label":"Vitamin C, Vitamin B1, Corticosteroids","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"In this study, we aim to determine whether the combination of Ascorbic Acid (Vitamin C), Thiamine (Vitamin B1), and Corticosteroids improves the trajectory of organ failure and reduces mortality in patients with sepsis and septic shock as compared to placebo.","primaryOutcome":{"measure":"Sequential Organ Failure Assessment (SOFA) Score at Baseline and 72 Hours","timeFrame":"Enrollment to 72-hours","effectByArm":[{"arm":"Vitamin C, Vitamin B1, Corticosteroids","deltaMin":9.1,"sd":3.5},{"arm":"Placebo","deltaMin":9.2,"sd":3.2}],"pValues":[{"comp":"OG000 vs OG001","p":"0.12"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":13,"countries":["United States"]},"refs":{"pmids":["27940189","28207287","26771781","33251516","32809003","31852712"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":101},"commonTop":[]}}